106 related articles for article (PubMed ID: 15596923)
21. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS
J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic Radiosurgery in the Multimodality Management of Residual or Recurrent Glioblastoma Multiforme.
Niranjan A; Monaco EA; Kano H; Flickinger JC; Lunsford LD
Prog Neurol Surg; 2018; 31():48-61. PubMed ID: 29393176
[TBL] [Abstract][Full Text] [Related]
23. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
[TBL] [Abstract][Full Text] [Related]
24. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.
Pichlmeier U; Bink A; Schackert G; Stummer W;
Neuro Oncol; 2008 Dec; 10(6):1025-34. PubMed ID: 18667747
[TBL] [Abstract][Full Text] [Related]
25. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
[TBL] [Abstract][Full Text] [Related]
26. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.
Langer CJ; Ruffer J; Rhodes H; Paulus R; Murray K; Movsas B; Curran W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):113-9. PubMed ID: 11516860
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
28. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513.
Fisher B; Won M; Macdonald D; Johnson DW; Roa W
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):980-6. PubMed ID: 12095566
[TBL] [Abstract][Full Text] [Related]
30. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.
Videtic GM; Gaspar LE; Zamorano L; Fontanesi J; Levin KJ; Kupsky WJ; Tekyi-Mensah S
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):687-92. PubMed ID: 10524423
[TBL] [Abstract][Full Text] [Related]
31. Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma.
Li J; Wang M; Won M; Shaw EG; Coughlin C; Curran WJ; Mehta MP
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):623-30. PubMed ID: 20888136
[TBL] [Abstract][Full Text] [Related]
32. Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide.
Thon N; Eigenbrod S; Grasbon-Frodl EM; Lutz J; Kreth S; Popperl G; Belka C; Kretzschmar HA; Tonn JC; Kreth FW
J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):441-6. PubMed ID: 20861061
[TBL] [Abstract][Full Text] [Related]
33. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
35. Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery.
Balagamwala EH; Miller JA; Reddy CA; Angelov L; Suh JH; Tariq MB; Murphy ES; Yang K; Djemil T; Magnelli A; Mohammadi AM; Soeder S; Chao ST
J Neurooncol; 2018 Apr; 137(2):289-293. PubMed ID: 29299738
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage.
Mehta MP; Masciopinto J; Rozental J; Levin A; Chappell R; Bastin K; Miles J; Turski P; Kubsad S; Mackie T
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):541-9. PubMed ID: 7928484
[TBL] [Abstract][Full Text] [Related]
37. Treatment of unresectable glioblastoma multiforme.
Nieder C; Grosu AL; Astner S; Molls M
Anticancer Res; 2005; 25(6C):4605-10. PubMed ID: 16334150
[TBL] [Abstract][Full Text] [Related]
38. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
[TBL] [Abstract][Full Text] [Related]
39. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
40. Evaluating glioma therapies: modeling treatments and predicting outcomes.
Kirby S; Brothers M; Irish W; Florell R; Macdonald D; Schold C; Cairncross G
J Natl Cancer Inst; 1995 Dec; 87(24):1884-8. PubMed ID: 7494233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
